2seventy bio, Inc. (TSVT) Misses Q4 EPS by 8c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q4 EPS of ($1.11), $0.08 worse than the analyst estimate of ($1.03). Revenue for the quarter came in at $10.68 million versus the consensus estimate of $14.78 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge